IP Issues in Antimonopoly Review of Undertaking Concentration

Similar documents
Intellectual property and competition policy

April 21, By to:

Patent Misuse. History:

Standard-Essential Patents

B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:

IS STANDARDIZATION FOR AUTONOMOUS CARS AROUND THE CORNER? By Shervin Pishevar

Settlement of Pharma Disputes and Competition Law in Korea

CPI Antitrust Chronicle October 2013 (1)

UNITED STATES INTERNATIONAL TRADE COMMISSION WASHINGTON, DC 20436

Guidelines on Standardization and Patent Pool Arrangements

FTC Approves Nielsen-Arbitron Transaction with Licensing and Divestiture Remedies

Modelss. patent legislation,

Issues at the Intersection of IP and Competition Policy

Working Guidelines. Question Q205. Exhaustion of IPRs in cases of recycling and repair of goods

Evolution of International Business

How Japanese Businesses Should Handle China s Emerging Approach to Antitrust and Intellectual Property

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

Nokia Technologies in 2016 Technology to move us forward.

19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights

Patents, Standards and the Global Economy

Patents, Standards and Antitrust: Patent Pools

Protecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence?

Flexibilities in the Patent System

WHO workshop on IP and Vaccines. Geneva 19 th -20 th April Introduction to the IP issues Christopher Garrison Consultant to WHO

Case No COMP/M i/ The Telegraph Group. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 7(3) Date:

The Ubiquity and Limits of Competition Policy in a World of Flux

Alternatives to Ex Ante Disclosure

Case M ACTIVISION BLIZZARD / KING. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 12/02/2016

Workshop on International R&D and Technology Transfer Contracts Negotiations, Intellectual Property Rights and Dispute Resolution

Identifying and Managing Joint Inventions

The 9 Sources of Innovation: Which to Use?

CPI Antitrust Chronicle April 2012 (2)

UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview

Comments on the Commission s draft Guidelines on the application of Article 101 TFEU on technology transfer agreements

FRAND UNDERTAKINGS IN STANDARDIZATION A BUSINESS PERSPECTIVE

Evaluating a Report of Invention & Licensing. Technology Development Boot Camp Peter Liao March 25, 2013

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development

Nigel Naihung Lee* (1)

The problem with software patents

Global strategy and plan of action on public health, innovation and intellectual property

Elements of a global strategy and plan of action

Open Systems Architecture in DoD Acquisition: Opportunities and Challenges

Intellectual Property

25 The Choice of Forms in Licensing Agreements: Case Study of the Petrochemical Industry

Committee on Industry, Research and Energy WORKING DOCUMENT. on Innovation Union: Transforming Europe for a post-crisis world

Industry Convergence in the Emerging Mobile Internet*

"Competition Policy and Intellectual Property Rights in the Republic of Latvia since 1991" (the working title)

SHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES

Intellectual Property Ownership and Disposition Policy

Measures for the Administration of Securities Investment within the Borders of China by Qualified Foreign Institutional Investors

rammed, J ammed & bifurcated: the convergence and divergence of intellectual property and competition policy in the digital environment

Establishing a Development Agenda for the World Intellectual Property Organization

Characters and Merchandising Rights

Observations from Pharma

TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Charles River Associates Annual Conference 8 December 2010, Brussels Opening address: The interplay between law and economics

USTR NEWS UNITED STATES TRADE REPRESENTATIVE. Washington, D.C UNITED STATES MEXICO TRADE FACT SHEET

GENEVA COMMITTEE ON DEVELOPMENT AND INTELLECTUAL PROPERTY (CDIP) Fifth Session Geneva, April 26 to 30, 2010

Cover Page. The handle holds various files of this Leiden University dissertation.

A. Notice to Inventors

The Role of Malaysian Patent Attorneys in Innovation and Transfer of Technology

Engaging Industry Partners

DRAFT AGENDA. OECD/Korean Policy Centre. Workshop on Merger Review Procedures and Joint Ventures. MOFCOM - Beijing, 25 June 2014

F98-3 Intellectual/Creative Property

How Industry Can Cooperate in Making an Application for Authorisation

Case No COMP/M BANCO SANTANDER / ABBEY NATIONAL. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 15/09/2004

THE EXECUTIVE BOARD OF DELFT UNIVERSITY OF TECHNOLOGY

THE IMPACT OF INTELLECTUAL PROPERTY PROTECTION ON INNOVATION AND TECHNOLOGY DEVELOPMENT

Historical Background, General Provisions and Basic Principles of the TRIPS Agreement and Transitional Arrangements*

NIS Transformation and Recombination Learning in China

Regional Seminar on the Effective Implementation and Use of Several Patent-Related Flexibilities

PLANNING YOUR COURSE OF STUDY (JURIS DOCTOR)

Intellectual Property Policy. DNDi POLICIES

Carnegie Endowment for International Peace

Standing Committee on the Law of Patents

The high cost of standardization How to reward innovators

The Green Economy: Trade and Sustainable Development Implications. From Rio to Rio:Technology Transfer, Innovation and Intellectual Property

BIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy


UNCITRAL Third International Colloquium on Secured Transactions Session on Contractual Guide on IP Licensing (Vienna, March 3, 2010)

Chapter 9a: Corporate Strategy: Strategic Alliances and Mergers & Acquisitions

Accepting Equity When Licensing University Technology

_prop_lab_partner.htm

Accepting Equity When Licensing University Technology

Lexis PSL Competition Practice Note

Acquisition of MST Medical Surgery Technologies Ltd:

INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH

Public Hearings Concerning the Evolving Intellectual Property Marketplace

Preamble. The United Nations Conference on an International Code of Conduct on the Transfer of Technology,

This Sticky is a response Note to AAG Delrahim's speech, consider the following:

Angel Financing. UNCP Entrepreneurial Summit UNCP Regional Center at COMtech Pembroke, NC 12 March Presented by:

Recent Development in Patent Exhaustion in Japan Speech for CASRIP High-Tech Summit 25. July Intellectual Property High Court of Japan

How Patent Damages Skew Licensing Markets

The EX ANTE DEBATE. Presented by. Monica M. Barone Sr. Legal Counsel Qualcomm. Monica M. Barone Sr. Legal Counsel Qualcomm

Role of Patents in Green Technology Transfer in the Context of Climate Change

IP and Technology Management for Universities

Deliverable D6.3 DeMStack

THE USE OF A RADIO FREQUENCY SPECTRUM AND SATELLITE ORBIT (Government Regulation No. 53/2000 dated July 11, 2000)

Case M SCHLUMBERGER / CAMERON. REGULATION (EC) No 139/2004 MERGER PROCEDURE. Article 6(1)(b) NON-OPPOSITION Date: 04/02/2016

Issues and Possible Reforms in the U.S. Patent System

Transcription:

IP Issues in Antimonopoly Review of Undertaking Concentration

Unconditionally Cleared Cases that involed IP Rights Issues For example, Google s acquisition of Motorola; Microsoft s acquisition of Nokia; Cleared Nokia s acquisition of Alcatel-Lucent; Subject to Merger between Dow Chemicals Commitments and DuPont.

Contents 1.Status of IP issues in antimonopoly review 2.IP issues and antimonopoly review principles 3. IP issues in market definition 4. IP issues in competition substantive analysis 5. IP issues in remedies

Point 1 Status of IP issues in antimonopoly review

Point 1 Status of IP issues in antimonopoly review IP constitutes an important part in antimonopoly review. It plays role in every aspect of undertaking concentration control regulations. The identification of a concentration, the calculation of turnover, the definition of relevant markets, the analysis and evaluation of competition effects and the assessment of remedies are all likely to bring up IP problems.

Point 1 Status of IP issues in antimonopoly review Examples: 1. The transfer or licensing of IP rights 2.Pooling arrangements

Point 2 IP issues and antimonopoly review principles

Point 2 IP issues and antimonopoly review principles General principle Principles Specific Principle

Point 2 IP issues and antimonopoly review principles General Principle The core of general principle lies in balance. We are always devoted to balancing innovation protection and competition promotion. We hold a prudent attitude towards conduct that uses antimonopoly law to challenge or intervene legitimate exercise of IP rights.

Point 2 IP issues and antimonopoly review principles Specific principle. The specific principle is observing the basic structure of Antimonopoly Law while taking into account the specific characteristics of IP. There is no need to create a special path for undertaking concentration involving IP issues. The appraisal criteria stipulated in Article 27 of Antimonopoly Law apply in the same way to cases involving IP issues. On basis of that, we weigh carefully the characteristics of the IP rights concerned in a specific case.

Point 3 IP issues in market definition

Point 3 IP issues in market definition Under Chinese law, antitrust analysis of technology transactions, licensing arrangements and other IP-related conduct might be required to define technology markets. It is not rare that we define a technology markets. However, it is not always necessary to do so. Normally, it is when mere defining relevant goods markets is not enough to capture competitive effects that we need to define a separate technology market.

Point 4 IP issues in competition substantive analysis

Point 4 IP issues in competition substantive analysis the incentive and intention of the transaction e.g. whether the incentive of the transaction is substantially related with the incentives. the mode of the transaction Different modes, such as merger, acquisition of shares, joint ventures, might differ in their influence on IP rights problems the involved IP right itself

Point 4 IP issues in competition substantive analysis the incentive and intention of the transaction the mode of the transaction the involved IP right itself e.g. the patents impact on upstream and downstream products, the undertaking s usual patent strategy, the impact on market entry, the licensee s countervailing power. SEPs might diminish the competition among technologies that existed before SEPs become the standard. Non-SEPs generally do not represent technical barriers unless otherwise indicated.

Point 5 IP issues in remedies

Point 5 IP issues in remedies Remedies ought to reduce or remove the possibility of IP rights abuse, while need take care of the protection of IP rights. Under certain circumstances IP rights do not always aim at a specific product market but are applicable to several markets. In such case, it is more appropriate to adopt behavioral remedies that impose compulsory license on fair reasonable and non-discriminatory terms, so that the notifying parties won t be burdened too much.

Point 5 IP issues in remedies Obligation to grant IP license Behavioral Remedies Setting terms and conditions for the granting Keeping the relevant business operating on a stand-alone-basis

Point 5 IP issues in remedies Furthermore, we have made many useful attempts in the assessment of behavioral conditions, such as the determination of goodfaith licensee in Microsoft s acquisition of Nokia and Nokia s acquisition of Alcatel-Lucent, which also exhibits the general principle of balance.

Thank you!